QH, Z., YT, Z., K, W., Q, D., ZY, C., D, T., . . . HB, X. (2025). Myeloid but not hepatocytic CD38 is a key driver for hepatic ischemia/reperfusion injury. Signal transduction and targeted therapy, 10(1), 150. https://doi.org/10.1038/s41392-025-02233-8
Chicago Style (17th ed.) CitationQH, Zhao, et al. "Myeloid but Not Hepatocytic CD38 Is a Key Driver for Hepatic Ischemia/reperfusion Injury." Signal Transduction and Targeted Therapy 10, no. 1 (2025): 150. https://doi.org/10.1038/s41392-025-02233-8.
MLA (9th ed.) CitationQH, Zhao, et al. "Myeloid but Not Hepatocytic CD38 Is a Key Driver for Hepatic Ischemia/reperfusion Injury." Signal Transduction and Targeted Therapy, vol. 10, no. 1, 2025, p. 150, https://doi.org/10.1038/s41392-025-02233-8.
Warning: These citations may not always be 100% accurate.
